Search

Companies planning to develop and commercialize medical devices or diagnostics face a challenging financing, regulatory, reimbursement and liability environment. Saul Ewing attorneys are experienced in helping medical device and diagnostic companies navigate these challenges. Many members of our...

As institutions of higher learning face increasingly public regulation from the Department of Education as well as state and other federal agencies, plaintiffs’ lawyers have taken note and begun to file class actions with increasing frequency. These claims tend to follow current events. Whether they...

Class actions filed against a company can quickly turn low-stake claims into litigation that can critically impact operations and create large exposures. Saul Ewing’s Class Actions Litigation Group guides clients through all phases of class action litigation defense, focusing on early-case...

Congressional investigations present these significant risks for individuals and organizations: investigations often arise suddenly and under the harsh glare of media attention investigators often make wide-ranging demands for documents and testimony timelines can be rapid and hard to predict...

A Unified Approach to Data Management The digital age has seen a dramatic increase in the amount of data generated year-over-year and remarkable growth in the number and variety of platforms companies use to conduct business. It can be challenging for any business to understand the universe of their...

Saul Ewing’s Litigation Department features approximately 200 attorneys across 18 offices. We handle a wide range of matters including complex business and commercial disputes, bet-the-company legal proceedings, and high-profile cases in state and federal courts and Alternative Dispute Resolution...

Comprehensive Guidance for Seizing and Optimizing Investments in Opportunity Zones In 2017, Congress created significant tax incentives for investment in Opportunity Zones. An investor who has recognized capital gains and makes a timely investment in a "Qualified Opportunity Fund" may (1) defer the...

Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...